acc01601 |
Probable RNA-binding protein EIF1AD |
phosphorylation |
Ser135 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01602 |
Protein KRI1 homolog |
phosphorylation |
Ser97 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01603 |
Transmembrane protein 87A |
phosphorylation |
Ser475 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01604 |
Transmembrane protein 87A |
phosphorylation |
Ser540 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01605 |
Reticulophagy regulator 2 |
phosphorylation |
Ser385 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01606 |
LEM domain-containing protein 2 |
phosphorylation |
Ser138 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01607 |
LEM domain-containing protein 2 |
phosphorylation |
Ser139 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01608 |
EH domain-binding protein 1 |
phosphorylation |
Ser432 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01609 |
EH domain-binding protein 1 |
phosphorylation |
Ser436 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01610 |
Serum response factor-binding protein 1 |
phosphorylation |
Ser281 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01611 |
Neuroguidin |
phosphorylation |
Ser142 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01612 |
Neuroguidin |
phosphorylation |
Ser143 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01613 |
InaD-like protein |
phosphorylation |
Ser1212 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01614 |
SWI/SNF complex subunit SMARCC2 |
phosphorylation |
Ser304 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01615 |
PEST proteolytic signal-containing nuclear protein |
phosphorylation |
Ser119 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01616 |
LIM domain only protein 7 |
phosphorylation |
Ser1593 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01617 |
Transcriptional repressor p66-beta |
phosphorylation |
Ser122 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01618 |
Protein ELYS |
phosphorylation |
Ser1513 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01619 |
E3 ubiquitin-protein ligase rififylin |
phosphorylation |
Ser229 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01620 |
DNA damage-binding protein 2 |
phosphorylation |
Ser26 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01621 |
Proteasome inhibitor PI31 subunit |
phosphorylation |
Ser252 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01622 |
Histone deacetylase 2 |
phosphorylation |
Ser394 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01623 |
Symplekin |
phosphorylation |
Ser1259 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01624 |
SWI/SNF complex subunit SMARCC1 |
phosphorylation |
Ser310 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01625 |
Bcl2-associated agonist of cell death |
phosphorylation |
Ser118 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01626 |
Connector enhancer of kinase suppressor of ras 1 |
phosphorylation |
Ser300 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01627 |
RAD51-associated protein 1 |
phosphorylation |
Ser21 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01628 |
Protein ARK2N |
phosphorylation |
Ser145 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01629 |
Proline-rich AKT1 substrate 1 |
phosphorylation |
Ser92 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01630 |
SH3 domain-containing kinase-binding protein 1 |
phosphorylation |
Ser509 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01631 |
SH3 domain-containing kinase-binding protein 1 |
phosphorylation |
Ser511 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01632 |
60S ribosomal export protein NMD3 |
phosphorylation |
Ser468 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01633 |
RalBP1-associated Eps domain-containing protein 1 |
phosphorylation |
Ser170 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01634 |
RNA-binding protein 33 |
phosphorylation |
Ser205 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01635 |
THO complex subunit 1 |
phosphorylation |
Ser560 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01636 |
PDZ and LIM domain protein 5 |
phosphorylation |
Ser360 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01637 |
Chromosome alignment-maintaining phosphoprotein 1 |
phosphorylation |
Ser507 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01638 |
Chromosome alignment-maintaining phosphoprotein 1 |
phosphorylation |
Ser452 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01639 |
Chromosome alignment-maintaining phosphoprotein 1 |
phosphorylation |
Ser204 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01640 |
Chromosome alignment-maintaining phosphoprotein 1 |
phosphorylation |
Ser319 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01641 |
Zinc finger RNA-binding protein |
phosphorylation |
Ser1054 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01642 |
Protein HEXIM2 |
phosphorylation |
Ser51 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01643 |
YTH domain-containing protein 1 |
phosphorylation |
Ser308 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01644 |
RNA-binding protein 14 |
phosphorylation |
Ser618 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01645 |
Protein IWS1 homolog |
phosphorylation |
Ser398 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01646 |
Protein cereblon |
phosphorylation |
Ser25 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01647 |
Remodeling and spacing factor 1 |
phosphorylation |
Ser604 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01648 |
Remodeling and spacing factor 1 |
phosphorylation |
Ser1345 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01649 |
Msx2-interacting protein |
phosphorylation |
Ser1382 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01650 |
Cell cycle checkpoint control protein RAD9A |
phosphorylation |
Ser375 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|